{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:58:40Z","timestamp":1791313120045,"version":"4.3.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03935-x","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T14:20:37Z","timestamp":1735654837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association between serum total indoxyl sulfate, intraperitoneal inflammation, and peritoneal dialysis technique failure: a 3-year prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1070-3602","authenticated-orcid":false,"given":"Natalia","family":"Stepanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-5532","authenticated-orcid":false,"given":"Victoria","family":"Driianska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-0326","authenticated-orcid":false,"given":"Lesya","family":"Korol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-0885","authenticated-orcid":false,"given":"Lyudmyla","family":"Snisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"issue":"12","key":"3935_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41581-022-00623-7","volume":"18","author":"AK Bello","year":"2022","unstructured":"Bello AK, Okpechi IG, Osman MA, Cho Y, Cullis B, Htay H, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022;18(12):779\u201393. https:\/\/doi.org\/10.1038\/s41581-022-00623-7.","journal-title":"Nat Rev Nephrol"},{"issue":"76","key":"3935_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.31450\/ukrjnd.4(76).2022.04","volume":"4","author":"I Shifris","year":"2022","unstructured":"Shifris I, Dudar I. Predictors of cardiovascular disease in peritoneal dialysis patients: a prospective longitudinal cohort study. Ukr J Nephrol Dialys. 2022;4(76):26\u201335. https:\/\/doi.org\/10.31450\/ukrjnd.4(76).2022.04.","journal-title":"Ukr J Nephrol Dialys"},{"issue":"2","key":"3935_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3747\/pdi.2011.00233","volume":"33","author":"JI Shen","year":"2013","unstructured":"Shen JI, Mitani AA, Saxena AB, Goldstein BA, Winkelmayer WC. Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013;33(2):155\u201366. https:\/\/doi.org\/10.3747\/pdi.2011.00233.","journal-title":"Perit Dial Int"},{"issue":"1","key":"3935_CR4","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1038\/s41598-018-22335-4","volume":"8","author":"JHC Chen","year":"2018","unstructured":"Chen JHC, Johnson DW, Hawley C, Boudville N, Lim WH. Association between causes of peritoneal dialysis technique failure and all-cause mortality. Sci Rep. 2018;8(1):3980. https:\/\/doi.org\/10.1038\/s41598-018-22335-4.","journal-title":"Sci Rep"},{"issue":"2","key":"3935_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000499749","volume":"48","author":"T Xie","year":"2019","unstructured":"Xie T, Bao M, Zhang P, Jiao X, Zou J, Ding X, et al. Serum concentration of Indoxyl Sulfate in Peritoneal Dialysis patients and low-flux hemodialysis patients. Blood Purif. 2019;48(2):183\u201390. https:\/\/doi.org\/10.1159\/000499749.","journal-title":"Blood Purif"},{"issue":"1","key":"3935_CR6","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1080\/0886022X.2022.2136528","volume":"44","author":"Z Chen","year":"2022","unstructured":"Chen Z, Xu J, Xing X, Xue C, Luo X, Gao S, et al. p-Cresyl sulfate predicts clinical outcomes in sustained peritoneal dialysis: a 5-year follow-up cohort study and meta-analysis. Ren Fail. 2022;44(1):1791\u2013800. https:\/\/doi.org\/10.1080\/0886022X.2022.2136528.","journal-title":"Ren Fail"},{"issue":"1","key":"3935_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12882-017-0457-1","volume":"18","author":"TW Kami\u0144ski","year":"2017","unstructured":"Kami\u0144ski TW, Pawlak K, Karbowska M, My\u015bliwiec M, Pawlak D. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. BMC Nephrol. 2017;18(1):35. https:\/\/doi.org\/10.1186\/s12882-017-0457-1.","journal-title":"BMC Nephrol"},{"issue":"2","key":"3935_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/hdi.12483","volume":"21","author":"X Tan","year":"2017","unstructured":"Tan X, Cao X, Zou J, Shen B, Zhang X, Liu Z, et al. Indoxyl sulfate, a valuable biomarker in chronic kidney disease and dialysis. Hemodial Int. 2017;21(2):161\u20137. https:\/\/doi.org\/10.1111\/hdi.12483.","journal-title":"Hemodial Int"},{"issue":"11","key":"3935_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/toxins12110684","volume":"12","author":"TH Cheng","year":"2020","unstructured":"Cheng TH, Ma MC, Liao MT, Zheng CM, Lu KC, Liao CH, et al. Indoxyl sulfate, a tubular toxin, contributes to the development of chronic kidney disease. Toxins (Basel). 2020;12(11):684. https:\/\/doi.org\/10.3390\/toxins12110684.","journal-title":"Toxins (Basel)"},{"issue":"3","key":"3935_CR10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/ijms22031135","volume":"22","author":"SF Rapa","year":"2021","unstructured":"Rapa SF, Prisco F, Popolo A, Iovane V, Autore G, Di Iorio BR, et al. Pro-inflammatory effects of Indoxyl Sulfate in mice: impairment of intestinal homeostasis and Immune Response. Int J Mol Sci. 2021;22(3):1135. https:\/\/doi.org\/10.3390\/ijms22031135.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3935_CR11","doi-asserted-by":"publisher","first-page":"e005022","DOI":"10.1161\/JAHA.116.005022","volume":"6","author":"SC Hung","year":"2017","unstructured":"Hung SC, Kuo KL, Wu CC, Tarng DC. Indoxyl sulfate: a Novel Cardiovascular Risk factor in chronic kidney disease. J Am Heart Assoc. 2017;6(2):e005022. https:\/\/doi.org\/10.1161\/JAHA.116.005022.","journal-title":"J Am Heart Assoc"},{"key":"3935_CR12","doi-asserted-by":"publisher","first-page":"36618","DOI":"10.1038\/srep36618","volume":"6","author":"E Sato","year":"2016","unstructured":"Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N, et al. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease. Sci Rep. 2016;6:36618. https:\/\/doi.org\/10.1038\/srep36618.","journal-title":"Sci Rep"},{"issue":"12","key":"3935_CR13","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/medicina59122189","volume":"59","author":"N Stepanova","year":"2023","unstructured":"Stepanova N, Tolstanova G, Aleksandrova I, Korol L, Dovbynchuk T, Driianska V, et al. Gut microbiota\u2019s oxalate-degrading activity and its implications on Cardiovascular Health in patients with kidney failure: a pilot prospective study. Med (Kaunas). 2023;59(12):2189. https:\/\/doi.org\/10.3390\/medicina59122189.","journal-title":"Med (Kaunas)"},{"issue":"9","key":"3935_CR14","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.3390\/ijms24098031","volume":"24","author":"A Ribeiro","year":"2023","unstructured":"Ribeiro A, Liu F, Srebrzynski M, Rother S, Adamowicz K, Wadowska M, et al. Uremic Toxin Indoxyl Sulfate promotes macrophage-Associated Low-Grade inflammation and epithelial cell senescence. Int J Mol Sci. 2023;24(9):8031. https:\/\/doi.org\/10.3390\/ijms24098031.","journal-title":"Int J Mol Sci"},{"key":"3935_CR15","doi-asserted-by":"publisher","first-page":"RP87316","DOI":"10.7554\/eLife.87316.1","volume":"12","author":"HY Kim","year":"2023","unstructured":"Kim HY, Kim DH, Lee SJ, Kang YJ, Kim G, Koh HB, et al. Uremic toxin indoxyl sulfate induces trained immunity via the AhR-dependent arachidonic acid pathway in ESRD. Elife. 2023;12:RP87316. https:\/\/doi.org\/10.7554\/eLife.87316.1.","journal-title":"Elife"},{"issue":"4","key":"3935_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12012-021-09718-2","volume":"22","author":"K Yamaguchi","year":"2022","unstructured":"Yamaguchi K, Yisireyili M, Goto S, Cheng XW, Nakayama T, Matsushita T, et al. Indoxyl sulfate activates NLRP3 inflammasome to Induce Cardiac Contractile Dysfunction accompanied by myocardial fibrosis and hypertrophy. Cardiovasc Toxicol. 2022;22(4):365\u201377. https:\/\/doi.org\/10.1007\/s12012-021-09718-2.","journal-title":"Cardiovasc Toxicol"},{"issue":"4","key":"3935_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3747\/pdi.2009.00092","volume":"30","author":"CT Lee","year":"2010","unstructured":"Lee CT, Kuo CC, Chen YM, Hsu CY, Lee WC, Tsai YC, et al. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis. Perit Dial Int. 2010;30(4):456\u201363. https:\/\/doi.org\/10.3747\/pdi.2009.00092.","journal-title":"Perit Dial Int"},{"issue":"1","key":"3935_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3747\/pdi.2012.00276","volume":"34","author":"L Viaene","year":"2014","unstructured":"Viaene L, Meijers BK, Bammens B, Vanrenterghem Y, Evenepoel P. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function. Perit Dial Int. 2014;34(1):71\u20138. https:\/\/doi.org\/10.3747\/pdi.2012.00276.","journal-title":"Perit Dial Int"},{"issue":"7","key":"3935_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jfma.2019.03.005","volume":"118","author":"PC Fan","year":"2019","unstructured":"Fan PC, Chang JC, Lin CN, Lee CC, Chen YT, Chu PH, et al. Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease. J Formos Med Assoc. 2019;118(7):1099\u2013106. https:\/\/doi.org\/10.1016\/j.jfma.2019.03.005.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"3935_CR20","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1038\/s41598-017-03130-z","volume":"7","author":"HY Kim","year":"2017","unstructured":"Kim HY, Yoo TH, Hwang Y, Lee GH, Kim B, Jang J, et al. Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD). Sci Rep. 2017;7(1):3057. https:\/\/doi.org\/10.1038\/s41598-017-03130-z.","journal-title":"Sci Rep"},{"issue":"6","key":"3935_CR21","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.3390\/ijms24065142","volume":"24","author":"G Caggiano","year":"2023","unstructured":"Caggiano G, Amodio L, Stasi A, Colabufo NA, Colangiulo S, Pesce F, et al. Gut-derived uremic toxins in CKD: an Improved Approach for the evaluation of serum indoxyl sulfate in clinical practice. Int J Mol Sci. 2023;24(6):5142. https:\/\/doi.org\/10.3390\/ijms24065142.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3935_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/ckj\/sfaa121","volume":"14","author":"S Yamamoto","year":"2020","unstructured":"Yamamoto S, Fuller DS, Komaba H, Nomura T, Massy ZA, Bieber B, et al. Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis outcomes and practice patterns study. Clin Kidney J. 2020;14(4):1236\u201343. https:\/\/doi.org\/10.1093\/ckj\/sfaa121.","journal-title":"Clin Kidney J"},{"issue":"1","key":"3935_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12882-022-02862-z","volume":"23","author":"Q Li","year":"2022","unstructured":"Li Q, Zhang S, Wu QJ, Xiao J, Wang ZH, Mu XW, et al. Serum total indoxyl sulfate levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study. BMC Nephrol. 2022;23(1):231. https:\/\/doi.org\/10.1186\/s12882-022-02862-z.","journal-title":"BMC Nephrol"},{"issue":"4","key":"3935_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000521422","volume":"47","author":"Z Li","year":"2022","unstructured":"Li Z, Ke G, Song L, Huang J, Zhang Y, Xiao J, et al. Association between Cardiac outcomes and indoxyl sulfate levels in Hemodialysis patients: a cross-sectional study. Kidney Blood Press Res. 2022;47(4):239\u201346. https:\/\/doi.org\/10.1159\/000521422.","journal-title":"Kidney Blood Press Res"},{"issue":"7","key":"3935_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.arcmed.2013.09.007","volume":"44","author":"CJ Lin","year":"2013","unstructured":"Lin CJ, Pan CF, Chuang CK, Liu HL, Sun FJ, Wang TJ, Chen HH, Wu CJ. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up. Arch Med Res. 2013;44(7):535\u201341. https:\/\/doi.org\/10.1016\/j.arcmed.2013.09.007.","journal-title":"Arch Med Res"},{"issue":"11","key":"3935_CR26","first-page":"20424","volume":"8","author":"L Zhou","year":"2015","unstructured":"Zhou L, Wen F, Chen G, Liu J, Liu H, Peng Y, et al. Cytokine profiles in peritoneal dialysis effluent predicts the peritoneal solute transport rate in continuous ambulatory peritoneal dialysis patients. Int J Clin Exp Med. 2015;8(11):20424\u201333.","journal-title":"Int J Clin Exp Med"},{"key":"3935_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/089686088700700306","volume":"7","author":"ZJ Twardowski","year":"1987","unstructured":"Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LR, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull. 1987;7:138\u201348.","journal-title":"Perit Dial Bull"},{"issue":"1","key":"3935_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/ajcn\/33.1.27","volume":"33","author":"PE Watson","year":"1980","unstructured":"Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33(1):27\u201339. https:\/\/doi.org\/10.1093\/ajcn\/33.1.27.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"3935_CR29","doi-asserted-by":"publisher","first-page":"18755","DOI":"10.1038\/s41598-022-23093-0","volume":"12","author":"J Pinto","year":"2022","unstructured":"Pinto J, Debowska M, Gomez R, Waniewski J, Lindholm B. Urine volume as an estimator of residual renal clearance and urinary removal of solutes in patients undergoing peritoneal dialysis. Sci Rep. 2022;12(1):18755. https:\/\/doi.org\/10.1038\/s41598-022-23093-0.","journal-title":"Sci Rep"},{"issue":"4","key":"3935_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/0896860820982218","volume":"41","author":"J Morelle","year":"2021","unstructured":"Morelle J, Stachowska-Pietka J, \u00d6berg C, Gadola L, La Milia V, Yu Z, et al. ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention. Perit Dial Int. 2021;41(4):352\u201372. https:\/\/doi.org\/10.1177\/0896860820982218.","journal-title":"Perit Dial Int"},{"key":"3935_CR31","first-page":"1","volume":"11","author":"AF Hiruy","year":"2021","unstructured":"Hiruy AF, Xiong Q, Guo X, Li L, Jin Q, Zhao J, et al. The Association between serum Indoxyl Sulfate, P-Cresyl Sulfate and Cardiovascular Risk factors in peritoneal Dialysis patients. J Nephrol Ther. 2021;11:1\u20139.","journal-title":"J Nephrol Ther"},{"issue":"1","key":"3935_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/0886022X.2020.1845731","volume":"42","author":"L Wang","year":"2020","unstructured":"Wang L, Xiang F, Ji J, Ding X, Shen B, Chen J, et al. Indoxyl sulfate and high-density lipoprotein cholesterol in early stages of chronic kidney disease. Ren Fail. 2020;42(1):1157\u201363. https:\/\/doi.org\/10.1080\/0886022X.2020.1845731.","journal-title":"Ren Fail"},{"issue":"12","key":"3935_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41579-023-00933-y","volume":"21","author":"SRS Fishbein","year":"2023","unstructured":"Fishbein SRS, Mahmud B, Dantas G. Antibiotic perturbations to the gut microbiome. Nat Rev Microbiol. 2023;21(12):772\u201388. https:\/\/doi.org\/10.1038\/s41579-023-00933-y.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"3935_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/j.jrn.2021.09.007","volume":"32","author":"X Lin","year":"2022","unstructured":"Lin X, Liang W, Li L, Xiong Q, He S, Zhao J, et al. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl sulfate in patients with end-stage Renal Disease. J Ren Nutr. 2022;32(5):578\u201386. https:\/\/doi.org\/10.1053\/j.jrn.2021.09.007.","journal-title":"J Ren Nutr"},{"issue":"5","key":"3935_CR35","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/microorganisms10050930","volume":"10","author":"N Tennoune","year":"2022","unstructured":"Tennoune N, Andriamihaja M, Blachier F. Production of Indole and Indole-Related compounds by the intestinal microbiota and consequences for the host: the Good, the bad, and the Ugly. Microorganisms. 2022;10(5):930. https:\/\/doi.org\/10.3390\/microorganisms10050930.","journal-title":"Microorganisms"},{"issue":"12","key":"3935_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5414\/CN109071","volume":"88","author":"CSB Sia","year":"2017","unstructured":"Sia CSB, Paul E, Tregaskis P, Walker RG, Wilson SG. The longitudinal effects of peritonitis on peritoneal membrane function. Clin Nephrol. 2017;88(12):311\u20136. https:\/\/doi.org\/10.5414\/CN109071.","journal-title":"Clin Nephrol"},{"issue":"2","key":"3935_CR37","doi-asserted-by":"publisher","first-page":"2286328","DOI":"10.1080\/0886022X.2023.2286328","volume":"45","author":"D Zhou","year":"2023","unstructured":"Zhou D, Lei H, Wu S, Yang W, Cui W, Li L, et al. Influencing factors for residual kidney function in incident peritoneal dialysis patients: a systematic review and meta-analysis. Ren Fail. 2023;45(2):2286328. https:\/\/doi.org\/10.1080\/0886022X.2023.2286328.","journal-title":"Ren Fail"},{"issue":"3","key":"3935_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/membranes12030276","volume":"12","author":"YH Chou","year":"2022","unstructured":"Chou YH, Chen YT, Chen JY, Tarng DC, Lin CC, Li SY. Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis patients. Membr (Basel). 2022;12(3):276. https:\/\/doi.org\/10.3390\/membranes12030276.","journal-title":"Membr (Basel)"},{"issue":"1","key":"3935_CR39","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1080\/0886022X.2021.1949350","volume":"43","author":"J Hu","year":"2021","unstructured":"Hu J, Zhang H, Yi B. Peritoneal transport status and first episode of peritonitis: a large cohort study. Ren Fail. 2021;43(1):1094\u2013103. https:\/\/doi.org\/10.1080\/0886022X.2021.1949350.","journal-title":"Ren Fail"},{"issue":"1","key":"3935_CR40","doi-asserted-by":"publisher","first-page":"2195014","DOI":"10.1080\/0886022X.2023.2195014","volume":"45","author":"S Guo","year":"2023","unstructured":"Guo S, Wu H, Ji J, Sun Z, Xiang B, Wu W, et al. Association between gut microbial diversity and technique failure in peritoneal dialysis patients. Ren Fail. 2023;45(1):2195014. https:\/\/doi.org\/10.1080\/0886022X.2023.2195014.","journal-title":"Ren Fail"},{"key":"3935_CR41","doi-asserted-by":"publisher","first-page":"639624","DOI":"10.3389\/fcimb.2022.639624","volume":"12","author":"M Bao","year":"2022","unstructured":"Bao M, Zhang P, Guo S, Zou J, Ji J, Ding X, et al. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients. Front Cell Infect Microbiol. 2022;12:639624. https:\/\/doi.org\/10.3389\/fcimb.2022.639624.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"3935_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.118.034588","volume":"139","author":"T Nakano","year":"2019","unstructured":"Nakano T, Katsuki S, Chen M, Decano JL, Halu A, Lee LH, et al. Uremic Toxin Indoxyl Sulfate promotes Proinflammatory Macrophage Activation Via the interplay of OATP2B1 and Dll4-Notch signaling. Circulation. 2019;139(1):78\u201396. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034588.","journal-title":"Circulation"},{"key":"3935_CR43","doi-asserted-by":"publisher","first-page":"976241","DOI":"10.1155\/2012\/976241","volume":"2012","author":"MW Fieren","year":"2012","unstructured":"Fieren MW. The local inflammatory responses to infection of the peritoneal cavity in humans: their regulation by cytokines, macrophages, and other leukocytes. Mediators Inflamm. 2012;2012:976241. https:\/\/doi.org\/10.1155\/2012\/976241.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"3935_CR44","doi-asserted-by":"publisher","first-page":"100645","DOI":"10.1016\/j.xkme.2023.100645","volume":"5","author":"N Stepanova","year":"2023","unstructured":"Stepanova N. The gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis. Kidney Med. 2023;5(6):100645. https:\/\/doi.org\/10.1016\/j.xkme.2023.100645.","journal-title":"Kidney Med"},{"issue":"7","key":"3935_CR45","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","volume":"27","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transpl. 2012;27(7):2686\u201393. https:\/\/doi.org\/10.1093\/ndt\/gfr624.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"3935_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nefro.2016.05.008","volume":"37","author":"S Cigarran Guldris","year":"2017","unstructured":"Cigarran Guldris S, Gonz\u00e1lez Parra E, Cases Amen\u00f3s A. Gut microbiota in chronic kidney disease. Nefrologia. 2017;37(1):9\u201319. https:\/\/doi.org\/10.1016\/j.nefro.2016.05.008.","journal-title":"Nefrologia"},{"key":"3935_CR47","doi-asserted-by":"publisher","first-page":"880097","DOI":"10.3389\/fneph.2022.880097","volume":"2","author":"JK Ng","year":"2022","unstructured":"Ng JK, Than WH, Szeto CC, Obesity. Weight gain, and Fluid overload in peritoneal Dialysis. Front Nephrol. 2022;2:880097. https:\/\/doi.org\/10.3389\/fneph.2022.880097.","journal-title":"Front Nephrol"},{"issue":"4","key":"3935_CR48","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000492148","volume":"46","author":"Y Shu","year":"2018","unstructured":"Shu Y, Liu J, Zeng X, Hong HG, Li Y, Zhong H, et al. The effect of overhydration on mortality and technique failure among peritoneal Dialysis patients: a systematic review and Meta-analysis. Blood Purif. 2018;46(4):350\u20138. https:\/\/doi.org\/10.1159\/000492148.","journal-title":"Blood Purif"},{"issue":"1","key":"3935_CR49","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12882-020-02178-w","volume":"21","author":"Q Dao Bui Quy","year":"2020","unstructured":"Dao Bui Quy Q, Pham Ngoc Huy T, Nguyen Duc L, Pham Van M, Nguyen Huu D, Nguyen Duy T, et al. Overhydration and low serum prealbumin predict peritoneal dialysis-related peritonitis in continuous ambulatory peritoneal dialysis patients. BMC Nephrol. 2020;21(1):512. https:\/\/doi.org\/10.1186\/s12882-020-02178-w.","journal-title":"BMC Nephrol"},{"key":"3935_CR50","doi-asserted-by":"publisher","first-page":"1220450","DOI":"10.3389\/fphys.2023.1220450","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Liu Y, Liu J. A review of research progress on mechanisms of peritoneal fibrosis related to peritoneal dialysis. Front Physiol. 2023;14:1220450. https:\/\/doi.org\/10.3389\/fphys.2023.1220450.","journal-title":"Front Physiol"},{"key":"3935_CR51","doi-asserted-by":"publisher","first-page":"1387292","DOI":"10.3389\/fimmu.2024.1387292","volume":"15","author":"H Su","year":"2024","unstructured":"Su H, Zou R, Su J, Chen X, Yang H, An N, Yang C, Tang J, Liu H, Yao C. Sterile inflammation of peritoneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma. Front Immunol. 2024;15:1387292. https:\/\/doi.org\/10.3389\/fimmu.2024.1387292.","journal-title":"Front Immunol"},{"key":"3935_CR52","doi-asserted-by":"publisher","first-page":"836861","DOI":"10.3389\/fmed.2022.836861","volume":"9","author":"Q Song","year":"2022","unstructured":"Song Q, Yang X, Shi Y, Yan H, Yu Z, Li Z, et al. High intraperitoneal interleukin-6 levels predict ultrafiltration (UF) insufficiency in peritoneal dialysis patients: a prospective cohort study. Front Med (Lausanne). 2022;9:836861. https:\/\/doi.org\/10.3389\/fmed.2022.836861.","journal-title":"Front Med (Lausanne)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03935-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03935-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03935-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T15:02:27Z","timestamp":1735657347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03935-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3935"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03935-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4077386\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the Declaration of Helsinki (Domestic Trial Registration Identifier 0117U002122). The study protocol was approved by the Ethics Committee of the State Institution \u201cInstitute of Nephrology of the National Academy of Medical Sciences\u201d, Kyiv, Ukraine ((Protocol #7, dated September 12, 2016)). Written, informed consent was obtained from all patients before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"475"}}